Clinical Trials Sponsored by Ocera Therapeutics, Inc.
Total 2950 results
-
Ocera Therapeutics, Inc.CompletedHepatic Encephalopathy | Acute Episode of Overt Hepatic EncephalopathyBelgium, Germany, Italy, Spain, United States, France, Austria, Russian Federation, Czechia, Australia, Hungary, Israel, Netherlands, Bulgaria, Estonia, Denmark, New Zealand
-
Ocera TherapeuticsCompletedMild Hepatic EncephalopathyUnited States
-
Ocera TherapeuticsCompletedIrritable Bowel SyndromeUnited States, Belgium
-
Ocera TherapeuticsCompletedIntestinal Fistula | Inflammatory Bowel DiseaseUnited States, Israel, Canada, United Kingdom, Germany, Belgium, Hungary, France, Austria, Czech Republic, Netherlands, Poland
-
Ocera TherapeuticsCompletedHepatic EncephalopathyUnited States
-
Ocera Therapeutics, Inc.No longer available
-
Ocera Therapeutics, Inc.Completed
-
Ocera TherapeuticsTerminatedGastroesophageal Reflux Disease (GERD)United States
-
Ocera TherapeuticsTerminatedPouchitisUnited States
-
Ocera TherapeuticsCompleted
-
Texas A&M UniversityOcera TherapeuticsUnknown
-
Acera Surgical, Inc.TerminatedWound HealUnited States
-
Acera Surgical, Inc.CompletedComparing Synthetic Hybrid-Scale Fiber Matrix With Standard of Care in Treating Diabetic Foot UlcersDiabetic Foot UlcerUnited States
-
Acera Surgical, Inc.Active, not recruitingDiabetic Foot Ulcer | Venous Leg UlcerUnited States
-
Acera Surgical, Inc.CompletedDiabetic Foot UlcerUnited States
-
BlackThorn Therapeutics, Inc.Neumora Therapeutics, Inc.CompletedMajor Depressive DisorderUnited States
-
Sirion Therapeutics, Inc.ReVision Therapeutics, Inc.CompletedGeographic Atrophy | Dry Age Related Macular Degeneration
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.Completed
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPsoriasis | Plaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedTinea PedisUnited States, Puerto Rico
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States, Georgia, Ukraine
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedA Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)Plaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedTinea Pedis | Tinea CrurisUnited States
-
Therapeutics, Inc.CompletedScalp PsoriasisUnited States
-
Therapeutics, Inc.CompletedAcne VulgarisUnited States
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedPsoriasis | Plaque PsoriasisUnited States
-
Therapeutics, Inc.CompletedA Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)Plaque PsoriasisUnited States
-
Chinook Therapeutics U.S., Inc.Active, not recruitingImmunoglobulin A Nephropathy | IgA NephropathyUnited States, Spain, Canada, Taiwan, Hong Kong, China, New Zealand, United Kingdom, Korea, Republic of, Australia, Germany, France, India, Japan, Czechia, Argentina, Italy, Colombia, Ireland, Brazil, Poland, Portugal
-
Millendo Therapeutics US, Inc.TerminatedCongenital Adrenal HyperplasiaSpain, Israel, France, Brazil, Czechia
-
Nebraska Methodist Health SystemAcera Surgical, Inc.TerminatedHead and Neck CancerUnited States
-
Chinook Therapeutics U.S., Inc.Active, not recruitingDiabetic Kidney Disease | Focal Segmental Glomerulosclerosis | Immunoglobulin A Nephropathy | IgA Nephropathy | Diabetic Nephropathy Type 2 | Alport SyndromeUnited States, Spain, Korea, Republic of, Australia, Italy, United Kingdom
-
Millendo Therapeutics US, Inc.TerminatedCushing SyndromeUnited States, United Kingdom
-
Bacainn Therapeutics, Inc.CompletedHealthy VolunteersUnited States
-
Cascadian Therapeutics Inc.Celldex TherapeuticsCompletedAdvanced Breast Carcinoma | Advanced Ovarian CarcinomaUnited States
-
Eikon TherapeuticsImpact Therapeutics, Inc.RecruitingAdvanced Solid TumorUnited States
-
ImmuneOncia Therapeutics Inc.Not yet recruitingA Study of Phase2, IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor (TMB-H)TMB-H | Histologically or Cytologically Proven Metastatic or Locally Advanced Solid Tumors
-
Axsome Therapeutics, Inc.RecruitingMajor Depressive DisorderUnited States
-
Actym Therapeutics, Inc.Not yet recruiting
-
Nested Therapeutics, IncRecruitingGlioma | Melanoma | NSCLC | Oncology | Solid Tumor, Adult | MEK Mutation | RAF Gene Mutation | Ras (KRAS or NRAS) Gene Mutation | MAPK Pathway Gene MutationAustralia
-
Viracta Therapeutics, Inc.Recruiting
-
Biora Therapeutics, Inc.Recruiting
-
Pliant Therapeutics, Inc.RecruitingMetastatic Solid TumorUnited States
-
Iambic Therapeutics, IncRecruiting